Summary tables comparing neoplastic disorders: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
| Line 45: | Line 45: | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:navy;" |'''CD23''' | |colspan="1" style = "font-size:90%; color:navy;" |'''CD23''' | ||
|colspan="1" style = "background:#004466;"| | |colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80 | ||
|colspan="1" style = "background:#00b8e6;"| | |colspan="1" style = "background:#66e0ff;color:black;font-size:80%""|5-20 | ||
|colspan="1" style = "background:#00b8e6;color:black; font-size:80%"|40:80 | |||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |CD25 | |colspan="1" style = "font-size:90%; color:black;" |CD25 | ||
Revision as of 19:23, 21 June 2023
| Immunophenotype LPD | |||
|---|---|---|---|
| Marker | CLL | MCL | FL |
| κ/λ | 40:80 wk | >80 | 40:80 |
| FMC7 | 20:40 wk | 40:80 | 40:80 |
| CD5 | >80 | >80 | <5% |
| CD10 | 5-20 | 5-20 | >80 Stg |
| CD11C | 20:40 wk | 20:40 wk | <5% |
| CD19 | >80 | >80 | 40:80 |
| CD20 | >80 | >80 | >80 |
| CD23 | >80 | 5-20 | 40:80 |
| CD25 | wk | ||
| CD38 | |||
| CD43 | |||
| CD79a | wk | ||
| CD103 | |||
| CD138 | |||
| CD200 | |||
Key to table:
Key to colour code Click for link
Key to expression code Click for link